retatrutide clinical study safety trials A new clinical trial from Eli Lilly and Company suggests its experimental Retatrutide for the treatment of

This delay in the action of the stomach can lead to symptoms like nausea, vomiting, bloating, early fullness, and abdominal pain

Fat Metabolism : Emerging research indicates that GLP-1 might influence how the body processes and stores fat, potentially favouring the use of fat for energy rather than storage

Expect 15-20% weight loss rather than full 24%

At this time, the program includes: Foundayo (tablet) Wegovy (injection and tablet) Zepbound KwikPen Not all formulations are covered

While the findings are encouraging, more India-specific research will help clarify how these benefits translate to local populations